DK2482799T3 - Farmaceutiske aerosolformuleringer af formoterol og beclometasondipropionat - Google Patents

Farmaceutiske aerosolformuleringer af formoterol og beclometasondipropionat

Info

Publication number
DK2482799T3
DK2482799T3 DK10763317.4T DK10763317T DK2482799T3 DK 2482799 T3 DK2482799 T3 DK 2482799T3 DK 10763317 T DK10763317 T DK 10763317T DK 2482799 T3 DK2482799 T3 DK 2482799T3
Authority
DK
Denmark
Prior art keywords
beclometasondipropionate
formoterol
aerosol formulations
pharmaceutical aerosol
pharmaceutical
Prior art date
Application number
DK10763317.4T
Other languages
English (en)
Inventor
Gaetano Brambilla
Original Assignee
Chiesi Farma Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42035850&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK2482799(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Chiesi Farma Spa filed Critical Chiesi Farma Spa
Application granted granted Critical
Publication of DK2482799T3 publication Critical patent/DK2482799T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/12Aerosols; Foams
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/537Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines spiro-condensed or forming part of bridged ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Otolaryngology (AREA)
  • Dispersion Chemistry (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK10763317.4T 2009-10-02 2010-09-27 Farmaceutiske aerosolformuleringer af formoterol og beclometasondipropionat DK2482799T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP09172083 2009-10-02
PCT/EP2010/005879 WO2011038872A1 (en) 2009-10-02 2010-09-27 Pharmaceutical aerosol formulations of formoterol and beclometasone dipropionate

Publications (1)

Publication Number Publication Date
DK2482799T3 true DK2482799T3 (da) 2014-09-01

Family

ID=42035850

Family Applications (2)

Application Number Title Priority Date Filing Date
DK14153337.2T DK2727582T3 (da) 2009-10-02 2010-09-27 Farmaceutiske aerosolformuleringer af formoterol og beclometasondipropionat
DK10763317.4T DK2482799T3 (da) 2009-10-02 2010-09-27 Farmaceutiske aerosolformuleringer af formoterol og beclometasondipropionat

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK14153337.2T DK2727582T3 (da) 2009-10-02 2010-09-27 Farmaceutiske aerosolformuleringer af formoterol og beclometasondipropionat

Country Status (21)

Country Link
US (1) US8420060B2 (da)
EP (2) EP2482799B1 (da)
KR (1) KR101778814B1 (da)
CN (2) CN102548537B (da)
AR (2) AR078494A1 (da)
BR (1) BR112012007484A2 (da)
CA (1) CA2776266C (da)
CY (2) CY1115266T1 (da)
DK (2) DK2727582T3 (da)
ES (2) ES2568913T3 (da)
HR (2) HRP20140818T1 (da)
HU (1) HUE029159T2 (da)
JO (1) JO3024B1 (da)
ME (1) ME02398B (da)
PL (2) PL2482799T3 (da)
PT (1) PT2482799E (da)
RS (2) RS53514B1 (da)
RU (1) RU2650175C2 (da)
SI (2) SI2727582T1 (da)
TW (1) TWI449523B (da)
WO (1) WO2011038872A1 (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9119777B2 (en) * 2008-05-30 2015-09-01 Microdose Therapeutx, Inc. Methods and compositions for administration of oxybutynin
MX368199B (es) * 2012-01-25 2019-09-24 Chiesi Farm Spa Formulación en polvo seco que comprende un corticoesteroide y un beta-adrenérgico para administración por inhalación.
US11052202B2 (en) * 2012-11-07 2021-07-06 Chiesi Farmaceutici S.P.A. Drug delivery device for the treatment of patients with respiratory diseases
EP3701940B1 (en) 2015-12-04 2025-11-12 Mexichem Fluor S.A. de C.V. Pharmaceutical composition
CN112438966B (zh) * 2019-08-30 2022-08-26 四川普锐特药业有限公司 一种医用定量吸入气雾剂
KR20220133193A (ko) * 2020-01-28 2022-10-04 키에시 파르마슈티시 엣스. 피. 에이. 완충된 약제학적 제제를 포함하는 가압 정량 흡입기

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5290539A (en) 1990-12-21 1994-03-01 Minnesota Mining And Manufacturing Company Device for delivering an aerosol
JP3172190B2 (ja) 1993-07-15 2001-06-04 ミネソタ マイニング アンド マニュファクチャリング カンパニー 医薬エアロゾルを配給するための器具
GB9612297D0 (en) * 1996-06-11 1996-08-14 Minnesota Mining & Mfg Medicinal aerosol formulations
US6423298B2 (en) * 1998-06-18 2002-07-23 Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceutical formulations for aerosols with two or more active substances
SE9900833D0 (sv) * 1999-03-09 1999-03-09 Astra Ab Novel combination
IT1317720B1 (it) 2000-01-07 2003-07-15 Chiesi Farma Spa Dispositivo per la somministrazione di aerosol dosati pressurizzati inpropellenti idrofluoroalcani.
JP5392880B2 (ja) 2000-05-22 2014-01-22 キエシ・フアルマチエウテイチ・ソチエタ・ペル・アチオニ 加圧式定量吸入器のための安定な製薬学的溶液製剤
US6472563B1 (en) * 2001-11-09 2002-10-29 Sepracor Inc. Formoterol tartrate process and polymorph
GB0205327D0 (en) * 2002-03-06 2002-04-17 Glaxo Group Ltd compounds
GB0323685D0 (en) * 2003-10-09 2003-11-12 Jagotec Ag Improvements in or relating to organic compounds
EP1982709A1 (en) * 2007-04-19 2008-10-22 CHIESI FARMACEUTICI S.p.A. Use of a composition comprising formoterol and beclomethasone dipropionate for the prevention or treatment of an acute condition of asthma
RU2356537C2 (ru) * 2007-07-25 2009-05-27 Закрытое Акционерное Общество (ЗАО) "Пульмомед" Фармацевтический состав дозированных аэрозолей, содержащий противоастматические лекарственные средства в виде суспензий, растворов, эмульсий, растворов и эмульсий

Also Published As

Publication number Publication date
EP2727582A1 (en) 2014-05-07
CN102548537B (zh) 2014-06-25
ES2487626T3 (es) 2014-08-22
CN103919785B (zh) 2016-08-24
RS54721B1 (sr) 2016-08-31
JO3024B1 (ar) 2016-09-05
AR123674A2 (es) 2023-01-04
RS53514B1 (sr) 2015-02-27
RU2012112454A (ru) 2013-11-10
CA2776266C (en) 2017-11-28
DK2727582T3 (da) 2016-05-17
EP2727582B1 (en) 2016-03-16
CN102548537A (zh) 2012-07-04
PL2727582T3 (pl) 2016-06-30
PL2482799T3 (pl) 2014-11-28
US8420060B2 (en) 2013-04-16
AR078494A1 (es) 2011-11-09
TW201119644A (en) 2011-06-16
ES2568913T3 (es) 2016-05-05
BR112012007484A2 (pt) 2020-06-09
HRP20160630T1 (hr) 2016-07-01
CY1117596T1 (el) 2017-04-26
EP2482799A1 (en) 2012-08-08
ME02398B (me) 2016-09-20
SI2482799T1 (sl) 2014-10-30
WO2011038872A1 (en) 2011-04-07
RU2650175C2 (ru) 2018-04-10
HRP20140818T1 (hr) 2014-10-10
CY1115266T1 (el) 2017-01-04
CN103919785A (zh) 2014-07-16
CA2776266A1 (en) 2011-04-07
PT2482799E (pt) 2014-08-06
KR101778814B1 (ko) 2017-09-15
EP2482799B1 (en) 2014-06-18
KR20120100901A (ko) 2012-09-12
HUE029159T2 (hu) 2017-02-28
HK1199214A1 (en) 2015-06-26
TWI449523B (zh) 2014-08-21
SI2727582T1 (sl) 2016-05-31
US20110081301A1 (en) 2011-04-07
HK1167817A1 (en) 2012-12-14

Similar Documents

Publication Publication Date Title
DK2493474T3 (da) Fremgangsmåder og sammensætninger til vedvarende afgivelse af lægemidler
DK3725330T3 (da) Stabile formuleringer af polypeptider og anvendelser heraf
DK2648742T3 (da) Formuleringer indeholdende saponiner og anvendelser deraf
DK3278665T3 (da) Stabil farmaceutisk sammensætning og fremgangsmåder til anvendelse deraf
DK3460056T3 (da) Terapeutiske nukleasesammensætninger og fremgangsmåder
DK2498756T3 (da) Tabletformuleringer af neratinibmaleat
DK2531181T3 (da) Formuleringer af rasagilin med forlænget afgivelse og anvendelser deraf
DK3345625T3 (da) Farmaceutisk sammensætning og indgivelser deraf
DK3202460T3 (da) Arylmethoxy-isoindolinderivater og sammensætninger omfattende og fremgangsmåder til anvendelser af samme
DK2275086T3 (da) Reduceret volumenformulering af glatirameracetat og fremgangsmåder til administration heraf
PL2575778T3 (pl) KOMPOZYCJE FARMACEUTYCZNE KOKRYSZTAŁÓW TRAMADOLU i KOKSYBÓW
DK3626258T3 (da) Fremgangsmåder og sammensætninger til cns-levering af iduronat-2-sulfatase
BRPI1008280A2 (pt) Formulações prebióticas e métodos mde uso
BR112012014962A2 (pt) métodos e composições para formulações líquidas e estáveis de fármacos
DK3045043T3 (da) Orale farmaceutiske sammensætninger af 3-hydroxy-n-methylmorphinan med forlænget frigivelse og fremgangsmåde til anvendelse
DK2410981T4 (da) Tørpulverformuleringer og fremgangsmåder til behandling af lungesygdomme
DK2558133T3 (da) Coatinger til fremstillingen og anvendelse af polyhydroxyalkanoat-lægemiddelindretninger
DK2475372T4 (da) Fremgangsmåde til fremstilling af micro-RNA og dets terapeutiske anvendelse
DK2220116T3 (da) Sammensætninger og fremgangsmåder til terapien og diagnosticeringen af influenza
DK3064579T3 (da) Farmaceutiske sammensætninger og medicinske anvendelsesformer af konstruerede humane arginaser
HRP20160579T1 (hr) Spoj indola i njegova farmaceutska upotreba
EP2515946A4 (en) NANOCONJUGATE AND NANOCONJUGATE FORMULATIONS
DK2413913T3 (da) Farmaceutiske formuleringer omfattende nitrocatecholderivater og fremgangsmåder til fremstilling deraf
PL2427416T3 (pl) Podstawione związki aromatyczne i ich zastosowania farmaceutyczne
DK2475649T3 (da) Indenonderivat og farmaceutisk sammensætning omfattende samme